Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO RESEARCH IN OPHTHALMOLOGY

November 2023

OPHTHALMOLOGY

INDEPENDENCE OF OCULAR BIOMARKERS OF CARDIAC RISK IN MACULAR DEGENERATION

Featuring: Rukhsana G. Mirza, MD

​​Recent research conducted by Rukhsana G. Mirza, MD, the Ryan-Pusateri Professor of Ophthalmology at Northwestern Medicine, published in Ophthalmology Retina, sheds light on the independence of ocular biomarkers of cardiac risk in macular degeneration. The study focuses on two specific biomarkers: Retinal ischemic perivascular lesions (RIPLs) and subretinal drusenoid deposits (SDDs). Both have been linked to an increased risk of cardiovascular disease. These biomarkers are believed to be caused by microvascular insults in different areas of the eye's circulation, suggesting a shared vascular mechanism.

In this retrospective, non-masked, cross-sectional observational study, the researchers examined 31 eyes of 17 patients with age-related macular degeneration (AMD). They counted the number of RIPLs and measured the percentage of macular area affected by SDDs. They found no correlation between the number of RIPLs and the percentage of macular area affected by SDDs (Pearson's r = 0.18, p = 0.3339).

This groundbreaking discovery suggests that RIPLs and SDDs occur independently in eyes with AMD. As a result, they may serve as separate predictors of cardiovascular disease risk. The implications are significant, as automated tools to identify RIPLs and SDDs could potentially streamline the estimation of cardiovascular risk for AMD patients during routine ophthalmology visits. This would enable clinicians to better identify high-risk patients and recommend further evaluation.
​
Excitingly, Dr. Mirza’s lab is collaborating with the Department of Computer Science in Northwestern University McCormick School of Engineering to develop automated tools using artificial intelligence. These tools aim to accurately identify RIPLs and SDDs, ultimately enhancing the assessment of cardiovascular risk in AMD patients.
​
Read more about the study >


Rukhsana G. Mirza, MD headshot
Rukhsana G. Mirza, MD, the Ryan-Pusateri Professor of Ophthalmology at Northwestern Medicine
​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM Ophthalmologist

You May Also Like

Picture

April 2023

OPHTHALMOLOGY
Case Report: Orbital Necrotizing Fasciitis Due to Severe Odontogenic Infection
Angelo P. Tanna, MD headshot

June 2022

OPHTHALMOLOGY
Reducing Health Disparities in Glaucoma Treatment
Picture

February 2023

OPHTHALMOLOGY
Preventive Anti-VEGF Therapy Does Not Improve Outcomes for Patients with NPDR

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties